French Biotech Lures Big Pharma with Fibrosis Treatments
This week, Inventiva has received a milestone payment from Boehringer Ingelheim and extended its collaboration with…
September 5, 2017 - 1 minute
Inventiva
French Biotech gets a Boost in the NASH Race with a Successful IPO
Inventiva has completed an IPO on Euronext Paris raising €48M that will support the advancement of its…
February 15, 2017 - 2 minutes
Not to be Underestimated: What’s the Hype around NASH?
Since 2014, investment in Non-Alcoholic SteatoHepatitis (NASH) has taken off with a fervor reminiscent of…
February 7, 2017 - 10 minutes
